EXPLORE THE EFFICACY AND SAFETY OF ONCE-DAILY ORAL RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION SCHEDULED FOR CARDIOVERSION
Cappato R., Ezekowitz M.D., Klein A.L., et al. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation // Eur. heart J. – 2014. Sep. 2. [Epub ahead of print].
Saved in:
| Format: | Article |
|---|---|
| Language: | Russian |
| Published: |
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
2016-03-01
|
| Series: | Неотложная медицинская помощь |
| Online Access: | https://www.jnmp.ru/jour/article/view/128 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|